journal
https://read.qxmd.com/read/37753246/efficacy-safety-and-durability-of-brolucizumab-an-8-month-post-marketing-surveillance-analysis
#1
JOURNAL ARTICLE
Nicholas J Saba, Scott D Walter
IMPORTANCE: Brolucizumab (Beovu® ) is an anti-vascular endothelial growth factor (anti-VEGF) agent approved for the treatment of neovascular age-related macular degeneration (nvAMD). Brolucizumab was marketed for its noninferiority to aflibercept and its potential for greater durability. However, post-marketing utilization has been tempered by safety concerns. OBJECTIVE: We evaluate the visual and anatomic efficacy of brolucizumab, examine changes in treatment intervals after switching to brolucizumab, and estimate the incidence of drug-related adverse events in the real world...
2023: Clinical Ophthalmology
https://read.qxmd.com/read/37750099/visual-and-refractive-outcomes-after-bilateral-implantation-of-a-biconvex-aspheric-toric-monofocal-intraocular-with-a-double-c-loop-haptic-design
#2
Robert Edward T Ang, Pedro Tañá-Rivero, Francisco Pastor-Pascual, Pavel Stodulka, Manfred Tetz, Isaak Fischinger
PURPOSE: To show the visual and refractive outcomes in cataract patients with corneal astigmatism when bilaterally implanted with a biconvex aspheric toric monofocal intraocular lens (IOL) with a double C-loop haptic-design. METHODS: Forty-seven cataract patients (94 eyes) with corneal astigmatism (≥0.75D) were implanted with the monofocal PODEYE toric IOL and assessed for 4-6 months post-surgery. Measurements included monocular and binocular uncorrected-distance visual acuity (UDVA) and corrected-distance visual acuity (CDVA), under both photopic and mesopic lighting conditions...
2023: Clinical Ophthalmology
https://read.qxmd.com/read/37750098/incidence-and-management-of-epithelial-related-complications-after-smile
#3
JOURNAL ARTICLE
Majid Moshirfar, Stephanie Zhang, Shreya Pandya, Isabella M Stoakes, Phillip C Hoopes
PURPOSE: To investigate the incidence and management of only epithelial-related complications following small incision lenticule extraction (SMILE). PATIENTS AND METHODS: A retrospective, single-site study analyzed patients who underwent SMILE at Hoopes Vision Clinic in Draper, Utah, from June 2017 to February 2023. Demographic data and preoperative parameters were reviewed. Postoperatively, patients were assessed for visual acuity and complications at different time points...
2023: Clinical Ophthalmology
https://read.qxmd.com/read/37743893/erratum-preservative-free-versus-benzalkonium-chloride-preserved-latanoprost-ophthalmic-solution-in-patients-with-primary-open-angle-glaucoma-or-ocular-hypertension-a-phase-3-us-clinical-trial-corrigendum
#4
https://read.qxmd.com/read/37743892/causes-of-moderate-to-severe-visual-impairment-and-blindness-among-children-in-integrated-schools-for-the-blind-and-visiting-a-tertiary-eye-hospital-in-nepal-the-nepal-pediatric-visual-impairment-npvi-study-letter
#5
JOURNAL ARTICLE
https://read.qxmd.com/read/37743891/intravitreal-ziv-aflibercept-versus-bevacizumab-for-na%C3%A3-ve-central-retinal-vein-occlusion-with-macular-edema-an-interim-analysis-of-a-randomized-non-inferiority-trial
#6
JOURNAL ARTICLE
Suthasinee Sinawat, Suthasinee Hemanak, Kwanchanok Chanthowong, Supat Sinawat, Yosanan Yospaiboon
PURPOSE: To compare the efficacy of intravitreal ziv-aflibercept (IVZ) and bevacizumab (IVB) injections for the treatment of macular edema secondary to central retinal vein occlusion. METHODS: Participants were randomly assigned 1:1 to receive 3 monthly IVZ (1.25 mg/0.05 mL) or IVB (1.25 mg/0.05 mL) followed by the pro-re-nata protocol for persistent or recurrent macular edema. The primary outcomes were best-corrected visual acuity and central subfield thickness...
2023: Clinical Ophthalmology
https://read.qxmd.com/read/37743890/clinical-research-on-the-leading-causes-of-severe-sight-impairment-in-the-uk-general-and-working-populations
#7
JOURNAL ARTICLE
Wei Jia Liu, Laura J Taylor, Robert E MacLaren, Jasleen K Jolly
PURPOSE: Clinical research brings the potential of improved diagnostics, sight-saving treatments, and more accessible services to those suffering with severe sight impairment (SSI). This report investigates whether registered ophthalmology clinical studies address the leading causes of SSI in the general and working populations of the United Kingdom (UK). METHODS: The latest statistics on the leading causes of SSI in the UK general and working populations were identified by searching PubMed, Cochrane Library, and TRIP databases...
2023: Clinical Ophthalmology
https://read.qxmd.com/read/37743889/using-light-meters-to-investigate-the-light-myopia-association-a-literature-review-of-devices-and-research-methods
#8
REVIEW
Astrid Hönekopp, Sarah Weigelt
With the increasing prevalence of myopia, evaluating its relationship with objective light exposure as a potential adjustable environmental factor in myopia development has been an emerging research field in recent years. From a thorough literature search, we identify ten wearable light meters from human studies on light exposure and myopia and present an overview of their parameters, thereby demonstrating the wide between-device variability and discussing its implications. We further identify 20 publications, including two reanalyses, reporting investigations of light-myopia associations with data from human subjects wearing light meters...
2023: Clinical Ophthalmology
https://read.qxmd.com/read/37736107/keratoconus-diagnosis-and-treatment-recent-advances-and-future-directions
#9
REVIEW
Anh D Bui, Angeline Truong, Neel D Pasricha, Maanasa Indaram
Keratoconus is a disorder characterized by progressive corneal thinning and steepening that may result in significant visual impairment secondary to high astigmatism, corneal scarring, or even corneal perforation. Early detection and screening of keratoconus are essential for effective management and treatment. Several screening methods, such as corneal topography and tomography, corneal biomechanics, and genetic testing, are being developed to detect keratoconus at an early stage. Once detected, prevention of progression is the mainstay of keratoconus management...
2023: Clinical Ophthalmology
https://read.qxmd.com/read/37720010/diagnosis-and-management-strategies-in-sclerochoroidal-calcification-a-systematic-review
#10
REVIEW
Ahmet Kaan Gündüz, Diğdem Tetik
Sclerochoroidal calcification (SCC) is a rare disease which is characterized by calcium deposition in the sclera. The choroid is secondarily involved. Typical localization is in the midperipheral region, outside the vascular arcades. SCC is mostly located in the superotemporal quadrant. Often times, the patients are referred with the diagnosis of an amelanotic tumor. SCC may be dystrophic or metastatic. Metastatic SCC lesions are associated with conditions altering calcium and phosphate metabolism including primary and secondary hyperparathyroidism, vitamin D intoxication, renal failure, hyperphosphatemia, and destructive bony lesions...
2023: Clinical Ophthalmology
https://read.qxmd.com/read/37720009/prevalence-and-determinants-of-symptomatic-dry-eye-disease-among-adult-urban-residents-of-high-altitude-areas-of-southwest-saudi-arabia-a-survey
#11
JOURNAL ARTICLE
Saad Abbas Aldawsari, Nazih Alzaidi, Maram E A Abdalla Elsayed, Abdullah Ahmed Alhammadi, Hadeel Khaled Alharthi, Abdulrahman Alosaimi, Yahya Al-Najmi
PURPOSE: To estimate the prevalence and determinants of Ocular Surface Disease Index (OSDI) score based dry eye disease (DED) among the adult urban population of four cities located at high altitudes in Southwest Saudi Arabia. METHODS: This cross-sectional survey was held in 2023. OSDI questionnaire was used to collect the responses of the adult participants. The score was further graded into none, mild, moderate, and severe DED to estimate age-sex-adjusted DED prevalence...
2023: Clinical Ophthalmology
https://read.qxmd.com/read/37720008/association-of-treatment-duration-and-clinical-outcomes-in-dry-eye-treatment-with-sutureless-cryopreserved-amniotic-membrane
#12
JOURNAL ARTICLE
Marguerite McDonald, Susan B Janik, Frank W Bowden, Amit Chokshi, Michael A Singer, Sean Tighe, Olivia G Mead, Seema Nanda, Mujtaba A Qazi, Damon Dierker, Adam T Shupe, Brittany J McMurren
BACKGROUND: While sutureless, cryopreserved amniotic membrane (cAM) has been shown to significantly improve signs and symptoms of dry eye disease (DED), no studies have assessed the association of cAM treatment duration to the differential response in clinical outcomes. METHODS: A multi-center, retrospective study was conducted on patients with moderate-to-severe DED who were treated with self-retained cAM (Prokera® Slim) for 2 to 7 days. The primary outcome measure was DEWS severity score assessed at 1 week, 1 month, and 3 months...
2023: Clinical Ophthalmology
https://read.qxmd.com/read/37705679/variability-of-replicates-of-intraocular-inflammatory-biomarkers-in-ocular-fluid-samples-analyzed-with-multiplex-assays
#13
JOURNAL ARTICLE
Daniel Lamoureux, David T Wong, Tina Felfeli
PURPOSE: Certain factors such as instrumental and sample processing errors may contribute to variability of ocular biofluid samples when they are run as replicates with multiplex assays. There is a paucity of literature on the variability of replicates in multiplex assays. This study aims to evaluate whether there is significant variability in replicate analyses of multiplex assays. METHODS: A total of 152 human ocular biofluid samples (51 aqueous humor and 101 vitreous) were collected and assayed for 27 cytokine biomarker concentrations (pg/mL)...
2023: Clinical Ophthalmology
https://read.qxmd.com/read/37701465/axial-length-correction-in-evaluation-of-refractive-predictability-and-biometry-agreement-response-to-letter
#14
COMMENT
Bjørn Gjerdrum, Kjell Gunnar Gundersen, Christian Nilsen, Morten Gundersen, Per Jensen
No abstract text is available yet for this article.
2023: Clinical Ophthalmology
https://read.qxmd.com/read/37701464/diagnostic-and-management-strategies-of-tubulointerstitial-nephritis-and-uveitis-syndrome-tinu-current-perspectives
#15
REVIEW
Julia Sanchez-Quiros, Lena Giralt, Alejandro Fonollosa, Ignacio Robles, Ester Carreño
Tubulointerstitial nephritis and uveitis (TINU) syndrome is a rare autoimmune disease with unclear pathogenesis but probably related to a combination of genetic predisposition and environmental triggers. Diagnosis is challenging due to the asynchronous onset of renal and ocular symptoms, and it is necessary to exclude other causes of nephritis and uveitis. It affects both sexes, with an overall predominance of females and a median age of onset of 15 years. TINU syndrome is characterized by bilateral, non-granulomatous anterior uveitis and tubulointerstitial nephritis, which can cause acute renal failure in severe cases...
2023: Clinical Ophthalmology
https://read.qxmd.com/read/37701463/optic-nerve-avulsion-pattern-and-etiologies-at-a-tertiary-eye-care-center-in-saudi-arabia-an-8-year-retrospective-study
#16
JOURNAL ARTICLE
Mohammad Al Amry, Lamia AlHijji, Sahar M Elkhamary, Ahmed Mousa, Abdulrahman AlGaeed, Huda AlGhadeer
PURPOSE: Optic nerve avulsion (ONA) is a rare but serious presentation of ocular trauma. This study investigates the presenting characteristics and etiologies of all cases of ONA over an 8-year-period at a tertiary eye care center in the Middle East. METHODS: The medical records of patients diagnosed with ONA at an Ophthalmic Emergency Department between November 2014 and November 2022 were analyzed in this retrospective cohort study. Data were collected on patient age, sex, affected eye, cause of injury and imaging studies...
2023: Clinical Ophthalmology
https://read.qxmd.com/read/37701462/comparing-the-accuracy-of-the-kane-barrett-universal-ii-hill-radial-basis-function-emmetropia-verifying-optical-and-ladas-super-formula-intraocular-lens-power-calculation-formulas
#17
JOURNAL ARTICLE
Majid Moshirfar, Christian A Sulit, Alex H Brown, Chase Irwin, Yasmyne C Ronquillo, Phillip C Hoopes
PURPOSE: To assess the accuracy of five new-generation intraocular lens (IOL) power formulas: Barrett Universal II (BUII), Emmetropia Verifying Optical (EVO) Formula, Hill-Radial Basis Function (Hill-RBF), Kane Formula, and Ladas Super Formula (LSF). PATIENTS AND METHODS: This is a retrospective single-surgeon study from a refractive clinic and clinical research center in Draper, UT, USA. The primary outcome measures were mean absolute error (MAE) and median absolute error (MedAE)...
2023: Clinical Ophthalmology
https://read.qxmd.com/read/37680744/preclinical-investigation-of-ab-interno-goniotomy-using-three-different-techniques
#18
JOURNAL ARTICLE
David A Ammar, Eric Porteous, Malik Y Kahook
PURPOSE: To evaluate incisional or excisional tissue-level effects of ab interno goniotomy techniques on human trabecular meshwork (TM). METHODS: The TM from human cadaveric corneal rim tissue was treated using three devices: (1) Kahook Dual Blade (KDB) GLIDE, (2) iAccess, and (3) SION. Two human corneal rims were used for each of the iAccess and SION devices and one with the KDB GLIDE, with 360 degrees of TM treated in each case. Sections were then prepared for analysis and comparison between devices...
2023: Clinical Ophthalmology
https://read.qxmd.com/read/37674592/real-world-outcomes-of-canaloplasty-and-trabeculotomy-combined-with-cataract-surgery-in-eyes-with-all-stages-of-open-angle-glaucoma
#19
JOURNAL ARTICLE
Arkadiy Yadgarov, Kallista Dentice, Qays Aljabi
PURPOSE: To evaluate the long-term safety and efficacy of sequential canaloplasty and trabeculotomy combined with cataract surgery in patients with mild, moderate, and advanced open-angle glaucoma. PATIENTS AND METHODS: Case records of 171 consecutive patients (171 eyes) who had undergone cataract surgery followed by canaloplasty (≥180°) and trabeculotomy (≥90°) for mild, moderate, or advanced open-angle glaucoma (Shaffer grade ≥3) using the OMNI Surgical System (Sight Sciences, Inc...
2023: Clinical Ophthalmology
https://read.qxmd.com/read/37674591/preservative-free-versus-benzalkonium-chloride-preserved-latanoprost-ophthalmic-solution-in-patients-with-primary-open-angle-glaucoma-or-ocular-hypertension-a-phase-3-us-clinical-trial
#20
Jason Bacharach, Iqbal Ike K Ahmed, Elizabeth D Sharpe, Michael S Korenfeld, Steven Zhang, Christophe Baudouin
PURPOSE: To evaluate the safety and efficacy of a preservative-free latanoprost 0.005% formulation (T2345) in patients with primary open-angle glaucoma (POAG) or ocular hypertension (OHT) compared to benzalkonium chloride-preserved latanoprost 0.005% (BPL) formulation in the United States (US). PATIENTS AND METHODS: A prospective, randomized, multicenter, observer-masked, parallel-group study enrolled 335 patients diagnosed with POAG or OHT from 31 US sites who had adequately controlled intraocular pressure (IOP; ≤18 mm Hg) with latanoprost monotherapy...
2023: Clinical Ophthalmology
journal
journal
41819
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.